Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hahn

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Neurology|March 8, 2017
Clinical Reasoning: A young woman with respiratory failure, hearing loss, and paraplegiaAchilles Ntranos, Hazem Shoirah, Mandip S Dhamoon, et al.
Clinical Pharmacology and Therapeutics|October 10, 2018
Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical StudyDavid Hahn, Chie Emoto, Joshua C Euteneuer, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2018
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small InfantsChie Emoto, Trevor N Johnson, Sibylle Neuhoff, et al.
Pharmacogenomics|April 6, 2016
Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropeniaAndrea Hahn, Tsuyoshi Fukuda, David Hahn, et al.
Neurology|August 30, 2017
Author response: Clinical Reasoning: A young woman with respiratory failure, hearing loss, and paraplegiaAchilles Ntranos, Hazem Shoirah, Mandip S Dhamoon, et al.
Clinical Pharmacology and Therapeutics|September 13, 2019
Next Challenge From the Variance in Individual Physiologically-Based Pharmacokinetic Model-Predicted to Observed Morphine Concentration in Critically Ill NeonatesChie Emoto, David Hahn, Joshua C Euteneuer, et al.
Journal of the American Board of Family Medicine : JABFM|September 20, 2017
Primary Care and Public Health Perspectives on Integration at the Local Level: A Multi-State StudyRebekah Pratt, Beth Gyllstrom, Kim Gearin, et al.
Vascular and Endovascular Surgery|June 15, 2011
Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive diseaseJoseph R Schneider, Michael J Verta, Marc J Alonzo, et al.
Journal of Clinical Pharmacology|February 25, 2020
Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric PatientsDavid Hahn, Tsuyoshi Fukuda, Joshua C Euteneuer, et al.
Journal of Child and Adolescent Psychopharmacology|May 9, 2019
Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive DisordersEthan A Poweleit, Stacey L Aldrich, Lisa J Martin, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Neurology|March 8, 2017
Clinical Reasoning: A young woman with respiratory failure, hearing loss, and paraplegiaAchilles Ntranos, Hazem Shoirah, Mandip S Dhamoon, et al.
Clinical Pharmacology and Therapeutics|October 10, 2018
Influence of OCT1 Ontogeny and Genetic Variation on Morphine Disposition in Critically Ill Neonates: Lessons From PBPK Modeling and Clinical StudyDavid Hahn, Chie Emoto, Joshua C Euteneuer, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2018
PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small InfantsChie Emoto, Trevor N Johnson, Sibylle Neuhoff, et al.
Pharmacogenomics|April 6, 2016
Pharmacokinetics and pharmacogenomics of β-lactam-induced neutropeniaAndrea Hahn, Tsuyoshi Fukuda, David Hahn, et al.
Neurology|August 30, 2017
Author response: Clinical Reasoning: A young woman with respiratory failure, hearing loss, and paraplegiaAchilles Ntranos, Hazem Shoirah, Mandip S Dhamoon, et al.
Clinical Pharmacology and Therapeutics|September 13, 2019
Next Challenge From the Variance in Individual Physiologically-Based Pharmacokinetic Model-Predicted to Observed Morphine Concentration in Critically Ill NeonatesChie Emoto, David Hahn, Joshua C Euteneuer, et al.
Journal of the American Board of Family Medicine : JABFM|September 20, 2017
Primary Care and Public Health Perspectives on Integration at the Local Level: A Multi-State StudyRebekah Pratt, Beth Gyllstrom, Kim Gearin, et al.
Vascular and Endovascular Surgery|June 15, 2011
Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive diseaseJoseph R Schneider, Michael J Verta, Marc J Alonzo, et al.
Journal of Clinical Pharmacology|February 25, 2020
Influence of MRP3 Genetics and Hepatic Expression Ontogeny for Morphine Disposition in Neonatal and Pediatric PatientsDavid Hahn, Tsuyoshi Fukuda, Joshua C Euteneuer, et al.
Journal of Child and Adolescent Psychopharmacology|May 9, 2019
Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive DisordersEthan A Poweleit, Stacey L Aldrich, Lisa J Martin, et al.
Pageof 5